– 96% Overall Response Rate, 74% Stringent Complete Response/Complete Response, and 95% Minimal Residual Disease Negativity Observed at a Median 15.9-months of Follow-up, with Responses Continuing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback